Allogene Therapeutics, Inc.ALLONASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
5Y CAGR+18.1%
Year-over-Year Change
Net other income and expenses outside core operations
5Y CAGR
+18.1%/yr
Long-term compound
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $18.43M | +14.8% |
| 2024 | $16.05M | +3300.8% |
| 2023 | $472000.00 | +109.7% |
| 2022 | $-4.88M | -162.4% |
| 2021 | $-1.86M | -123.2% |
| 2020 | $8.02M | -53.0% |
| 2019 | $17.08M | +191.0% |
| 2018 | $-18.78M | - |
| 2017 | $0.00 | - |